Joseph Ciaffoni
President and CEO at Collegium Pharmaceutical Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Collegium Pharmaceutical Inc., 3 years.
Collegium Pharmaceutical Inc.
Director · President and CEO
Chief executive roles
Collegium Pharmaceutical Inc.
· President and CEO
Until November 2024
· Former
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 12, 2024 | Collegium Pharmaceutical Inc. | Grant or award | +119,000 | — | — |
| Feb 12, 2024 | Collegium Pharmaceutical Inc. | Grant or award | +179,734 | — | — |
| Feb 12, 2024 | Collegium Pharmaceutical Inc. | Shares withheld for tax | −47,445 | $33.70 | $1,598,897 |
| Feb 12, 2024 | Collegium Pharmaceutical Inc. | Shares withheld for tax | −81,422 | $33.70 | $2,743,921 |
| Dec 21, 2023 | Collegium Pharmaceutical Inc. | Option exercise | +4,357 | $21.34 | $92,978 |
| Dec 21, 2023 | Collegium Pharmaceutical Inc. | Open-market sale | −4,357 | $30.38 | $132,366 |
| Dec 20, 2023 | Collegium Pharmaceutical Inc. | Option exercise | +26,454 | $21.34 | $564,528 |
| Dec 20, 2023 | Collegium Pharmaceutical Inc. | Open-market sale | −26,454 | $30.40 | $804,202 |
| Dec 19, 2023 | Collegium Pharmaceutical Inc. | Option exercise | +14,516 | $21.34 | $309,771 |
| Dec 19, 2023 | Collegium Pharmaceutical Inc. | Open-market sale | −14,516 | $30.03 | $435,915 |
| Dec 18, 2023 | Collegium Pharmaceutical Inc. | Option exercise | +27,798 | $21.34 | $593,209 |
| Dec 18, 2023 | Collegium Pharmaceutical Inc. | Open-market sale | −27,798 | $30.04 | $835,052 |
| Jun 2, 2023 | Collegium Pharmaceutical Inc. | Open-market sale | −30,272 | $21.58 | $653,270 |
| Jun 2, 2023 | Collegium Pharmaceutical Inc. | Open-market sale | −1,000 | $22.25 | $22,250 |
| Jun 1, 2023 | Collegium Pharmaceutical Inc. | Open-market sale | −31,272 | $22.09 | $690,798 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.